Equine Rabies Immunoglobulin (ERIG) Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Equine Rabies Immunoglobulin (ERIG) Market size is expected to grow at an annual average CAGR of 5% during 2022-2028. Rabies immune globulin (RIG) products are used during prophylaxis after exposure.(PEP) locally neutralizing the rabies virus at the wound site while simultaneouslyRabies vaccines are on the rise. RIG is derived from horse plasma (eRIG).or human (hRIG). Despite extensive data demonstrating both safety and safetyeRIGs, even when available, are not always used, in part due to previous medical practice.Concerns about the historical use of horse serum or crude eRIG.

The following segmentation are covered in this report:

By Application

• Category II Exposure
• Category III Exposure

By Type

• 1500IU
• 1000IU
• 400IU
• Other

Company Profile

• Serum China
• Lanzhou Institute of Biological Products
• Wuhan Institute of Biological Products
• Premium Serums
• Haffkine Bio-Pharmaceutical
• Bharat Serums

Scope of the report

The research study analyses the Equine Rabies Immunoglobulin (ERIG) Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Equine Rabies Immunoglobulin (ERIG) Market Report

• What was the Equine Rabies Immunoglobulin (ERIG) Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Equine Rabies Immunoglobulin (ERIG) Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.